"At Empire Eye and Laser Center, we strive to provide quality care through the latest, most advanced technologies available. We also recognize that even the greatest medical developments are only as good as the difference they make in people's lives. We, therefore, emphasize that the most important person in the practice is you, the patient."

During the past decade, Empire Eye & Laser Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Empire Eye & Laser Center" are "Cataract" (11 trials), "Cataracts" (3 trials), "Corneal Astigmatism" (3 trials), "Glaucoma" (1 trials) and "Meibomian Gland Dysfunction" (1 trials). Many other conditions were trialed in "Empire Eye & Laser Center" in a lesser frequency.

Most popular intervention types in "Empire Eye & Laser Center" are "Device" (16 trials). Other intervention types were less common.

The name of intervention was led by "Activator LFD-2100" (1 trials), "Control Group" (1 trials), "Control Healon EndoCoat" (1 trials), "Healon5 OVD" (1 trials) and "Higher Cylinder Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Empire Eye & Laser Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Empire Eye & Laser Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Empire Eye & Laser Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Empire Eye & Laser Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".